Skip to main content
. 2016 Feb 2;12(1):156–162. doi: 10.5114/aoms.2016.57592

Table I.

Correlation between FUBP1 mRNA expression in brain glioma tissue and pathological differentiation

Differentiation (grade) Number of cases FUBP1 mRNA expression relative quantification (gliomas/peri-cancerous tissues) P-value
Medium-well differentiated (grade I–II) 23 1.724 ±0.163 < 0.05*
Anaplastic glioma (grade III) 11 1.824 ±0.185
Glioblastoma (GBM, grade IV) 9 1.853 ±0.178

A one-way ANOVA showed that FUBP1 mRNA expression in brain glioma tissue was significantly different among the three groups with different pathological differentiation of glioma (p < 0.05). The LSD test showed significant difference between groups of medium-well differentiated glioma (grade I–II) and anaplastic glioma (grade: III) (p = 0.03), as well as groups of medium-well differentiated glioma (grade I–II) and glioblastoma (GBM, grade: IV) (p = 0.01).